Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hodgkin's Lymphoma, Relapsed, Adult”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00625729
What this trial is testing

Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Masonic Cancer Center, University of Minnesota 6
Early research (Phase 1)Looking for participantsNCT03017820
What this trial is testing

A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma

Who this might be right for
B-Cell Non-Hodgkin LymphomaHistiocytic and Dendritic Cell NeoplasmMyelodysplastic Syndrome+16 more
Mayo Clinic 99
Early research (Phase 1)Study completedNCT00019656
What this trial is testing

Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT02456675
What this trial is testing

INCB040093 and INCB040093 Combined With Itacitinib (INCB039110) in Relapsed/Refractory Hodgkin Lymphoma

Who this might be right for
Refractory Hodgkin LymphomaRecurrent Adult Hodgkin's Lymphoma
Incyte Corporation 8
Testing effectiveness (Phase 2)Ended earlyNCT04035434
What this trial is testing

A Safety and Efficacy Study Evaluating CTX110 in Subjects With Relapsed or Refractory B-Cell Malignancies (CARBON)

Who this might be right for
B-cell MalignancyNon-Hodgkin LymphomaB-cell Lymphoma+1 more
CRISPR Therapeutics AG 93
Early research (Phase 1)Study completedNCT00110071
What this trial is testing

Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Burkitt Lymphoma+12 more
Fred Hutchinson Cancer Center 38
Early research (Phase 1)Study completedNCT00002765
What this trial is testing

Immunotoxin in Treating Patients With Leukemia or Lymphoma

Who this might be right for
LeukemiaLymphoma
National Cancer Institute (NCI)
Early research (Phase 1)Active Not RecruitingNCT04464200
What this trial is testing

19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers

Who this might be right for
Diffuse Large B Cell LymphomaPrimary Mediastinal Large B Cell LymphomaTransformed Follicular Lymphoma to Diffuse Large B Cell Lymphoma+6 more
Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00003245
What this trial is testing

Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Looking for participantsNCT05702853
What this trial is testing

Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL

Who this might be right for
B-cell Non Hodgkin LymphomaChronic Lymphocytic Leukemia
Medical University of South Carolina 27
Large-scale testing (Phase 3)Study completedNCT00053053
What this trial is testing

Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer

Who this might be right for
CachexiaLymphomaLymphoproliferative Disorder+1 more
Radiation Therapy Oncology Group 472
Testing effectiveness (Phase 2)Ended earlyNCT00383565
What this trial is testing

FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Recurrent Adult Diffuse Large Cell LymphomaRecurrent Mantle Cell Lymphoma
National Cancer Institute (NCI) 9
Early research (Phase 1)Study completedNCT05233033
What this trial is testing

Safety, PK/PD, and Clinical Activity of KT-413 in Adult Patients with Relapsed or Refractory B-cell NHL

Who this might be right for
Non Hodgkin LymphomaDiffuse Large B Cell LymphomaDLBCL+1 more
Kymera Therapeutics, Inc. 7
Testing effectiveness (Phase 2)Study completedNCT00002663
What this trial is testing

Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies

Who this might be right for
EBV-induced LymphomasEBV-associated MalignanciesTransplant Patients With EBV Viremia at High Risk of Developing a Recurrent EBV Lymphoma
Atara Biotherapeutics 58
Testing effectiveness (Phase 2)Study completedNCT00059904
What this trial is testing

Rituximab and Interleukin-2 in Treating Patients With Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Looking for participantsNCT05595447
What this trial is testing

Treatment Strategy for Relapsed/Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin LymphomaRefractory Hodgkin LymphomaRelapsed Hodgkin's Disease, Adult
Hospital Regional de Alta Especialidad del Bajio 20
Testing effectiveness (Phase 2)Study completedNCT00782379
What this trial is testing

Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes
Northside Hospital, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT01008462
What this trial is testing

Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

Who this might be right for
B-Cell Prolymphocytic LeukemiaHypodiploidyLoss of Chromosome 17p+18 more
Fred Hutchinson Cancer Center 16
Early research (Phase 1)UnknownNCT00769613
What this trial is testing

Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections

Who this might be right for
Cancer
Milton S. Hershey Medical Center 20
Early research (Phase 1)Study completedNCT00561418
What this trial is testing

Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma

Who this might be right for
LymphomaSmall Intestine Cancer
Ohio State University Comprehensive Cancer Center 23
Next Page